Coagulant Therapeutics

Clotprotect Therapeutics

This company develops small molecule anti-fibrinolytic drugs for patients suffering from acute haemorrhage and severe bleeding.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

Cayuga Biotech

This company develops biomimetic injectable drugs to control life-threatening hemorrhage for patients suffering from trauma, childbirth complications or surgical bleeding.

VarmX

This biotech company develops recombinant blood clotting factors to treat patients with severe bleeding or requiring urgent surgery while taking oral anticoagulants.

Alveron Pharma

Alveron Pharma develops a cyclodextrin-based injectable drug that reverses anticoagulant and antiplatelet effects for patients experiencing life-threatening bleeding emergencies and haemorrhagic strokes.

HemostOD

The company develops stem cell-derived platelets for transfusion and targeted drug delivery, serving healthcare providers and pharmaceutical partners treating blood disorders or trauma.

LUNAC Therapeutics

This drug discovery company develops next-generation anticoagulant therapies for patients requiring treatment for pathological blood clots with minimal bleeding risk.

RougeTx

This biotechnology company develops small-molecule therapies that restore vascular stability to treat patients with hereditary haemorrhagic telangiectasia and other bleeding disorders.